The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eisner Mark since 2023.
This trader's CIK number is 1834161.
At the time of last reporting, Eisner Mark was the EVP, Chief Medical Officer of Fibrogen Inc. (stock ticker symbol FGEN).
Also see all insider trading activities at Fibrogen Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | FGEN | 0 | $0 | 31,004 | $614,316 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-07 | FGEN | Sale | 2,042 | 17.04 | 34,791 |
| 2023-06-02 | FGEN | Sale | 1,090 | 18.83 | 20,524 |
| 2023-04-04 | FGEN | Sale | 9,182 | 18.78 | 172,474 |
| 2023-03-10 | FGEN | Sale | 10,140 | 20.20 | 204,797 |
| 2023-03-08 | FGEN | Sale | 7,363 | 21.16 | 155,771 |
| 2023-03-02 | FGEN | Sale | 1,187 | 21.87 | 25,959 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eisner Mark (EVP, Chief Medical Officer of Fibrogen Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.